⌘K

Home/Filings/4/0001562180-25-004866

4//SEC Filing

Gengos Andrew 4

Accession 0001562180-25-004866

CIK 0001831363other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 6:05 PM ET

Size

7.7 KB

Accession

0001562180-25-004866

Insider Transaction Report

Form 4

Period: 2025-06-13

Terns Pharmaceuticals, Inc.TERN

Chief Financial Officer

Transactions

Purchase
Common Stock
2025-06-13$3.75/sh+5,000$18,750→ 5,000 total
Purchase
Common Stock
2025-06-16$3.95/sh+5,000$19,733→ 15,000 total
Purchase
Common Stock
2025-06-13$3.72/sh+5,000$18,600→ 10,000 total

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Terns Pharmaceuticals, Inc.

CIK 0001831363

Entity typeother

Related Parties

1

filerCIK 0001563623

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 6:05 PM ET
Size: 7.7 KB

View on SEC.gov